Skip to main content
. 2021 Jan 3;26(1):206. doi: 10.3390/molecules26010206
CTLA-4 Cytotoxic T-lymphocyte antigen-4
GBA Gut Brain Axis
EBV Epstein–Barr virus
HIV Human Immunodeficiency Virus
HPV Human Papilloma
HPTLV-1 Type 1 human T-cell lymphotropic virus
Hb-B Hepatitis B
Hb-C Hepatitis C
DMAB 3, 2′-dimethyl-4-aminobiphenol
NHMI Nitrosoheptamethyleneimine
DEN N-nitrosodiethylamine
COPD Chronic obstructive pulmonary disease
CCl4 Carbon Tetra Chloride
DCA Deoxycholic Acid
DNA Deoxyribonucleic Acid
MALT Mucosa-associated lymphoid tissue
ISPID Immunoproliferative small intestinal disease
TNF Tumor Necrosis Factor
MAMP Microbiome associated molecular pattern
TLR Toll Like Receptors
LPS Lipopolysaccharides
CRC Colorectal Cancer
SCFA Short Chain Fatty Acids
DSS Dextran Sulfate Sodium
AOM Azoxymethane
TIGIT T cell immunoreceptor with Ig and ITIM domains
IL Interleukin
BC Breast Cancer
rRNA ribosomal Ribonucleic Acid
NAFLD Non-alcoholic liver fatty liver disease
HCC Hepatocellular carcinoma
mAbs monoclonal Antibodies
PD-1 programmed cell death protein1
PD-L1 programmed cell death ligand protein 1
ICIs Immune Check point Inhibitors
TME Tumor Microenvironment
APCs Antigen Presenting Cells
FMT Faecal Microbial Transplantation
HSCT hematopoietic stem cell transplantation
MDACC MD Anderson Cancer Centre
ICB immune checkpoint blockade
GVHD Graft versus host disease
Th17 Thyroxin receptor 17
pDC plasmacytoid DC (Dendritic cells)
TILs Tumor Infiltrating Lymphocytes
BiTEs Bispecific T-cell engagers
CAR Chimeric Antigen Receptor
ACT Adoptive Cell Therapy
CDI Clostridium difficali infection
CNS Central Nervous System
ANS Autonomous Nervous System
ENS Enteric Nervous System
GABA Gama Amino Butyric Acid
mTOR mammalian target of rapamycin
GALT Gut Associated lymphoid tissues
NK Natural Killer cells
DC Dendritic cells
MPL Monophosphoryl Lipid